Entity > Corporation > US > New York City New York > Accelerate Diagnostics

About Accelerate Diagnostics

Accelerate Diagnostics, Inc is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections.

Accelerate Diagnostics’ Technology: The cornerstone of the ability to provide breakthrough diagnostic solutions hinges on developing technologies that address the needs of clinicians. Accelerate Diagnostics work with healthcare partners across the globe to ensure our innovations lead to critical answers that drive improved treatment options for patients.

Accelerate Diagnostics offers the Accelerate Pheno® System and the Accelerate PhenoTest® BC Kit: Accelerate Pheno® System is everything you need to get MIC-based antimicrobial susceptibility results with identification in a simple, disposable kit. One system for your identification and susceptibility results. Fast and fully automated fluorescence in-situ hybridization drives pathogen detection, species identification, and quantitation. Independent studies show that the Accelerate PhenoTest® BC Kit provides identification and susceptibility results with MICs approximately 40 hours faster than conventional methods. Now you can use your existing ID test to get fast AST results using the Accelerate PhenoTest BC kit. Input ID results automatically or manually for the AST configuration. It’s your lab after all, so do it your way.

Accelerate Diagnostics Was Established in 1987: The company began research activity for microbiology solutions in 2004 and relaunched in 2012 as Accelerate Diagnostics, Inc. to develop and commercialize its first diagnostic platform. The company is headquartered in Tucson, AZ, United States, and Eindhoven , The Netherlands.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Accelerate Diagnostics